Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
Clinical trial NCT07226648 · RECRUITING
Trial details
- NCT number
- NCT07226648
- Sponsor
- SPIRE Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-11
- Primary completion
- 2026-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.